Last reviewed: June 26, 2026
Last updated: June 26, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide (sold as Ozempic for diabetes and Wegovy for weight loss) is not approved for use during pregnancy, and animal studies suggest potential risks to fetal development. If you become pregnant while on GLP-1 therapy, the standard medical recommendation is to discontinue the medication right away and work with your healthcare provider on a safe transition plan.
Why Semaglutide Is Not Safe During Pregnancy
Semaglutide has not been studied in pregnant people, and FDA labeling includes a pregnancy category warning. Animal reproduction studies showed dose-related effects on fetal development at exposures similar to human therapeutic doses. This does not mean semaglutide causes birth defects in humans—rather, the data gap and animal signals mean the risk cannot be ruled out.
The hormone GLP-1 (glucagon-like peptide-1) does play a role in fetal pancreatic development in early pregnancy. Blocking GLP-1 signaling with semaglutide during this critical window could theoretically interfere with normal development, though human evidence remains limited. Because pregnancy involves rapid hormonal and metabolic shifts, introducing a powerful weight-loss medication during this period introduces unnecessary uncertainty for both mother and baby.
When to Stop Semaglutide if You're Trying to Conceive
If you're actively trying to become pregnant, inform your prescribing doctor before your next dose. Most specialists recommend stopping semaglutide at least 2–3 months before attempting conception, though some guidelines suggest a shorter washout. Semaglutide clears the body relatively quickly (half-life ~7 days), but the longer window allows time for your metabolism and hormones to stabilize before pregnancy begins.
If you have been taking semaglutide and discover you are pregnant unexpectedly, do not panic. Contact your doctor or OB-GYN the same day if possible to confirm pregnancy and review your medication history. A single dose taken before you knew you were pregnant is very unlikely to cause harm, but your medical team will want to assess your individual timeline and risk profile.
Weight Management During and After Pregnancy Without GLP-1
Pregnancy is not the time to pursue aggressive weight loss, even if you used semaglutide successfully before conception. Healthy weight gain during pregnancy (typically 25–35 pounds for people with normal BMI) supports fetal development and maternal health. Your focus should shift from weight loss to balanced nutrition, safe exercise, and managing blood sugar if you have gestational diabetes.
After delivery and throughout breastfeeding, GLP-1 therapy remains off-limits because semaglutide passes into breast milk and its long-term safety in infants is unknown. Once you have finished breastfeeding and cleared any postpartum recovery period (usually 6–12 weeks postpartum), you and your doctor can explore restarting semaglutide if weight management remains a goal. PlexusDx can support your return to personalized therapy at that time with updated dosing based on your postpartum health.
How PlexusDx Supports Safe Medication Transitions
PlexusDx compounded semaglutide injections start at $149/month and are sourced from licensed 503A compounding pharmacies. Before starting or changing any GLP-1 therapy—including planning for pregnancy—PlexusDx requires a medical consultation to confirm suitability and review your health history. Our platform ensures you have direct access to qualified prescribers who understand contraindications like pregnancy.
The Precision Peptide Genetic Test ($99 add-on after first month) maps 14 metabolic pathways including variants in GLP1R, GIPR, FTO, and MC4R genes that influence your response to semaglutide. Understanding your genetic predispositions can help you and your doctor make informed choices about whether GLP-1 therapy is right for you before or after pregnancy, ensuring you resume treatment with confidence when it is safe to do so.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What should I do immediately if I find out I'm pregnant while taking semaglutide?
Stop taking semaglutide right away and contact your OB-GYN or primary care doctor the same day to confirm pregnancy and review your medication timeline. A single dose taken before you knew you were pregnant is unlikely to cause harm, but your medical team will want to document your exposure and monitor your pregnancy with appropriate care. Do not resume semaglutide until after breastfeeding ends, typically 6–12 months or more postpartum.
Can I take semaglutide while breastfeeding?
No. Semaglutide is excreted into breast milk, and its safety in nursing infants has not been established. You should wait until you have stopped breastfeeding completely before restarting GLP-1 therapy. Once you and your baby are no longer nursing, you can consult with PlexusDx about resuming personalized semaglutide treatment.
How long before trying to get pregnant should I stop taking semaglutide?
Most reproductive health specialists recommend stopping semaglutide 2–3 months before you begin trying to conceive, though some consider a shorter window acceptable given semaglutide's rapid clearance (7-day half-life). This timing allows your hormones and metabolism to fully normalize before conception. Discuss your specific timeline with your OB-GYN or family planning doctor, as individual factors may apply.
Is there any evidence that semaglutide causes birth defects in humans?
No confirmed human birth defect cases have been attributed to semaglutide exposure, and pregnancy registries continue to monitor outcomes. However, animal studies showed fetal developmental effects at therapeutic doses, which is why semaglutide is contraindicated in pregnancy. The lack of human data means risks cannot be definitively ruled out, so stopping the medication is the safest approach.
Can PlexusDx help me restart semaglutide safely after pregnancy?
Yes. Once you have finished breastfeeding and cleared postpartum recovery with your OB-GYN, PlexusDx can support your return to compounded semaglutide therapy ($149/month start) with a fresh medical consultation and updated health assessment. The Precision Peptide Genetic Test can also help identify your unique metabolic profile to optimize your dosing and response, ensuring you resume treatment with personalized insight.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Can Wegovy Stop Working After a Year? Managing Plateaus and Long-Term Success
How to Not Gain Weight After Stopping Wegovy